Novavax Inc. shares fell as much as 24% after US regulators placed a hold on the company’s experimental influenza and Covid-19 combination vaccines because a study volunteer developed a serious nerve ...

Pharmacies and residents in Eastern North Carolina take preventative measures to protect against respiratory illness after ...

The project — in collaboration with Erasmus University in the Netherlands — is supported by a recent $7 million grant from ...

Electronic nudges had a small impact on flu vaccine uptake in patients without diabetes but showed no significant effect ...

Dr. Wes Stubblefield with the Alabama Department of Public Health says this year's flu season will look a lot like last year's.

An infant, and a 90+ year-old adult, were the first Connecticut residents to die from the flu in the 2024-25 season.

Sanofi (SNYNF, SNY) said that the U.S. Food and Drug Administration has updated the label for FLUBLOK (Influenza Vaccine) to include ...

This is a tragic reminder that the 2024-25 respiratory viral disease season is here,” the Connecticut commissioner said.

Respiratory virus season is underway, but Washington is more prepared than it was last year to protect against some severe ...

Flu season is almost here, and there is a respiratory syncytial virus (RSV) vaccine update worth monitoring. Earlier today, ...

The hold, which was made in response to a serious adverse event report, could impact the company’s plans to start a Phase 3 trial of a combination shot for COVID-19 and influenza.

The clinical hold affects Novavax’s COVID-flu combo and standalone flu vaccines, which were on the cusp of Phase III testing.